Delivering medical device software solutions with Microbira
Microbira, a UK-based company founded in 2019, enhances healthcare delivery using artificial intelligence (AI) and Fourier Transform Infrared (FTIR) spectroscopy. These technologies enable rapid and accurate diagnostics, addressing critical challenges in clinical and research settings.
To advance this mission further, Microbira collaborated with Oxford Computer Consultants (OCC) to transform an existing researcher toolkit into an enhanced web application. This partnership focused on creating a scalable, secure, and user-friendly platform. Importantly, the platform meets regulatory standards from the laboratory to commercialisation.
Reflecting on the collaboration, Marianne Ismail, CEO of Microbira, shared:
“From the time Microbira was introduced to Oxford Computer Consultants by our Clinical Consulting Company, the OCC team understood our project needs immediately. We wanted a reputable company familiar with clinical software development and the entire process, including regulatory approvals, from the lab to commercialisation.”
Key Achievements
- Improved result management and analysis: The new application streamlines workflows, enabling efficient handling and interpretation of diagnostic data.
- Real-time client-specific outputs: Users can now generate customised reports quickly, enhancing the relevance of diagnostic results.
- Remote sample submission: The platform allows users to submit samples online, broadening access and fostering greater collaboration.
- Enhanced security: Robust data protection measures ensure compliance with industry standards and safeguard sensitive information.
Moreover, OCC’s expertise in clinical software development was crucial in delivering a solution that aligned with Microbira’s goals. The project aimed to create reagent-free, rapid, and cost-effective in vitro diagnostic tools for clinical and research usage.
This collaboration demonstrates how combining technological innovation with specialised software development drives significant advancements. Such partnerships ultimately improve patient care and public health outcomes, highlighting the importance of innovation.
Click below to read the full case study
